DOW vs VRTX · P/E 74, rev $39.97B vs P/E 30, rev $3.33B
Dow Inc (DOW) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the DOW and VRTX stock pages for the full models.
Not investment advice.